Skip to content
★ Sign in to follow
KR

Kirk R. Maples

Executive
Anacor Pharmaceuticals, Inc.
Total declarations
80
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (63 ops.)
€3.7M

Latest filing published 02 Jun 2015 for Anacor Pharmaceuticals, Inc., €32k.

Insider track record

Disclosed buys
0
Disclosed sells
63
Signal history

No signal scores available.

Kirk R. Maples: trading record in brief

All filings by Kirk R. Maples on record concern Anacor Pharmaceuticals, Inc. We count 80 filings; the first trade dates from 24 May 2011 and the latest from 1 June 2015.

On the market, this insider has only sold: 63 sales, €3.7M in total. The rest of the record consists of 4 share grants and 13 option exercises. Since January 2015: no purchases and 10 sales on the market.

The record was last updated on 2 June 2015 with an open-market sale (€32k) in Anacor Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Kirk R. Maples

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations79 total

25 of 79 declarations